Cue Biopharma, Inc. Annual Nonoperating Income (Expense) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Cue Biopharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
  • Cue Biopharma, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $212K, a 36.1% decline year-over-year.
  • Cue Biopharma, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $1.35M, a 41.2% increase year-over-year.
  • Cue Biopharma, Inc. annual Nonoperating Income (Expense) for 2023 was $1.42M, a 559% increase from 2022.
  • Cue Biopharma, Inc. annual Nonoperating Income (Expense) for 2022 was $215K, a 368% increase from 2021.
  • Cue Biopharma, Inc. annual Nonoperating Income (Expense) for 2021 was $45.9K, a 90.1% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.42M +$1.2M +559% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $215K +$169K +368% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $45.9K -$418K -90.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-21
2020 $464K -$18.9K -3.91% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
2019 $483K -$58.6K -10.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $541K +$541K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $35.00* Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.